TLSI: צמיחת מכירות רבעונית TriSalus Corp

לוגו תאגידי של חברת TriSalus Life Sciences, Inc. (TLSI)

TriSalus Life Sciences (TLSI) operates its own facility in the US that integrates medical devices and tumor therapy drugs. On GURU.Markets, the QoQ revenue growth rate demonstrates current dynamics, where the value of 11.40 reflects this status. Business stability relies on exclusive patents and strict FDA control, while platform development proceeds through partnerships with leading oncology centers without engaging in M&A transactions.

TLSI גידול רבעוני בהכנסות TriSalus (21.02.2024 - 20.11.2026)

פילוחי מדדים ואנליטיקה של חברת TriSalus Life Sciences, Inc. (TLSI)

- מחיר מניה ומחיר יעד קונצנזוס:
ניתוח כל מדדי החברה:TLSI - TriSalus Life Sciences
מוצר סדרתי של trisaluslifesci.com

TriSalus Life Sciences is developing a tumor-fighting platform through partnerships with oncology centers without utilizing mergers. This metric measures the growth rate of three-month sales, reflecting the recovery speed of commercial flows. The investor analyzes this data to assess the business model's resilience to external shocks. By examining this quarterly revenue chart, one can determine the actual strength of the company's financial position under current conditions.